Aim: To evaluate possible results with the stimulation use of minoxidil and the strengthening of hair roots with nutritional cyclical supplements, resulting in increased hair regrowth, without the use of anti androgens and enzyme blockers.Methods: This prospective controlled clinical trial compares the current acknowledged form of treatment for hair loss within two controlled groups for both men and women against the use of cyclical nutritional therapy and minoxidil 2%. One hundred patients in each of the 4 groups, a total of 400 patients, were followed for 1 year. The progress was evaluated every 2 months with computerised measurements of hair density, hair calibre, global photography and uniquely designed self-assessment scores.Results: T...
Eighty male patients with AGA, not treated in the previous 6 months were enrolled in this randomized...
BackgroundAndrogenetic alopecia (AGA) affects almost half the population, and several treatments int...
BackgroundAndrogenetic alopecia (AGA) affects almost half the population, and several treatments int...
Aim The purpose of the present research was to assess the treatment effects of various pharmaceutica...
Background It has not been conclusively established that female pattern hair loss (FPHL) is either d...
Background: Androgenetic alopecia is the commonest type of alopecia affecting over half of men and w...
Background: Finasteride acts by reducing dihydrotestosterone levels, thereby inhibiting miniaturizat...
IntroductionCurrently, only topical minoxidil (MNX) and oral finasteride (FNS) are approved by the F...
Background: Androgenetic alopecia (AGA) affects almost half the population, and several treatments i...
In this 24-week, open-label study, the safety and efficacy of topically applied 2% minoxidil solutio...
Objective: This study was conducted to evaluate the combination of oral supplements with 2% minoxidi...
Objective: Androgenetic Alopecia (AGA) is a common cause of hair loss among male. Two FDA approved d...
The efficacy of mesotherapy in the treatment of female pattern hair loss (FPHL) has not yet been eva...
BACKGROUND: Minoxidil and spironolactone are oral antihypertensives known to stimulate hair growth. ...
Androgenetic alopecia (AGA), or male pattern baldness, has a negative impact on people's quality of ...
Eighty male patients with AGA, not treated in the previous 6 months were enrolled in this randomized...
BackgroundAndrogenetic alopecia (AGA) affects almost half the population, and several treatments int...
BackgroundAndrogenetic alopecia (AGA) affects almost half the population, and several treatments int...
Aim The purpose of the present research was to assess the treatment effects of various pharmaceutica...
Background It has not been conclusively established that female pattern hair loss (FPHL) is either d...
Background: Androgenetic alopecia is the commonest type of alopecia affecting over half of men and w...
Background: Finasteride acts by reducing dihydrotestosterone levels, thereby inhibiting miniaturizat...
IntroductionCurrently, only topical minoxidil (MNX) and oral finasteride (FNS) are approved by the F...
Background: Androgenetic alopecia (AGA) affects almost half the population, and several treatments i...
In this 24-week, open-label study, the safety and efficacy of topically applied 2% minoxidil solutio...
Objective: This study was conducted to evaluate the combination of oral supplements with 2% minoxidi...
Objective: Androgenetic Alopecia (AGA) is a common cause of hair loss among male. Two FDA approved d...
The efficacy of mesotherapy in the treatment of female pattern hair loss (FPHL) has not yet been eva...
BACKGROUND: Minoxidil and spironolactone are oral antihypertensives known to stimulate hair growth. ...
Androgenetic alopecia (AGA), or male pattern baldness, has a negative impact on people's quality of ...
Eighty male patients with AGA, not treated in the previous 6 months were enrolled in this randomized...
BackgroundAndrogenetic alopecia (AGA) affects almost half the population, and several treatments int...
BackgroundAndrogenetic alopecia (AGA) affects almost half the population, and several treatments int...